Author:
McCullough Deanna C.,Eraso Kathryn M.,Kaunitz Andrew M.
Publisher
Springer International Publishing
Reference72 articles.
1. Centers for Disease Control and Prevention: U.S. Selected Practice Recommendations for Contraceptive Use, 2013: Adapted from the World Health Organization Selected Practice Recommendations for Contraceptive Use, 2nd edition. Morbidity and Mortality Weekly Report: Recommendations and Reports. 2013;62:1–60.
2. Trussell J. Contraceptive failure in the United States. Contraception. 2011;83(5):397–404.
3. Curtis KM, Tepper NK, Jatlaoui TC, et al. U S. medical eligibility criteria for contraceptive use, 2016. MMWR Recomm Rep. 2016;65(3):1–103.
4. Mishell DR Jr. Pharmacokinetics of depot medroxyprogesterone acetate contraception. J Reprod Med. 1996;41:381–90.
5. Paulen ME, Curtis KM. When can a woman have repeat progestogen-only injectables--depot medroxyprogesterone acetate or norethisterone enantate? Contraception. 2009;80(4):391–408.